Search

Search Constraints

You searched for: Author/Creator Makanga, Mumbi

Search Results

1. High prevalence of sexually transmitted infections among women screened for a contraceptive intravaginal ring study, Kisumu, Kenya, 2014. (December 2018)

2. Third-line antiretroviral therapy in low-income and middle-income countries (ACTG A5288): a prospective strategy study. Issue 9 (September 2019)

3. Third‐line antiretroviral therapy, including raltegravir (RAL), darunavir (DRV/r) and/or etravirine (ETR), is well tolerated and achieves durable virologic suppression over 144 weeks in resource‐limited settings: ACTG A5288 strategy trial. Issue 6 (15th June 2022)